close


close
SYNVISC packaging
genzyme corporationresearchgenzyme websites
Information for patientsContact Us
HomeAbout SYNVISCClinical Info and ResearchReimbursement ResourcesOrdering SYNVISCPatient Education
SYNVISC

In Step with SYNVISC®

Living with OA of the knee can be challenging, so it's important for your patients to have support.
In Step with SYNVISC is a free program that provides instant access to an easy-to-use website.
Go to instepwithsynvisc.com and see how your patients can get the information and support they need at every stage of treatment.

Recommend In Step with SYNVISC to your patients to help you:

  • Provide information about OA of the knee—with a comprehensive educational resource and articles archive
  • Enhance doctor/patient communication—with interactive tools that monitor treatment and track pain
  • Keep your patients motivated—with special offers from the Arthritis Foundation, email newsletters, and quarterly magazines




Important Safety Information

SYNVISC® (hylan G-F 20) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics, e.g., acetaminophen. In clinical trials, the most commonly reported adverse events were transient local pain, swelling, and/or effusion in the injected knee. In some cases, these symptoms have been extensive. Other side effects such as rash have been reported rarely.

SYNVISC is contraindicated in patients with known hypersensitivity to hyaluronan products or patients with infections in or around the knee. Use caution when using SYNVISC in patients allergic to avian proteins, feathers, or egg products; who have evidence of venous or lymphatic stasis in the leg to be treated; or who have severe inflammation in the knee joint to be treated. Patients should be advised to avoid strenuous or prolonged weight-bearing activities after treatment. Strict adherence to aseptic technique must be followed to avoid joint infection. The safety and effectiveness of SYNVISC in children and in pregnant or lactating women have not been established. It is unknown whether SYNVISC is excreted in human milk.

View the Complete Prescribing Information for SYNVISC (PDF, 146k)